Candel Therapeutics (CADL) Insider Trading & Ownership $7.00 +0.04 (+0.57%) Closing price 04:00 PM EasternExtended Trading$7.04 +0.04 (+0.63%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Candel Therapeutics (NASDAQ:CADL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage16.60%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$7.50MNumber OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$987.38K Get CADL Insider Trade Alerts Want to know when executives and insiders are buying or selling Candel Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CADL Insider Buying and Selling by Quarter Candel Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/30/2025William Garrett NicholsInsiderSell781$5.04$3,936.24 3/17/2025Charles SchochInsiderSell5,000$8.83$44,150.00 3/17/2025Seshu TyagarajanCTOSell31,278$8.82$275,871.96 1/15/2025Francesca BaroneInsiderSell13,534$7.22$97,715.48 1/15/2025Seshu TyagarajanCTOSell14,322$7.22$103,404.84 1/8/2025Francesca BaroneInsiderSell13,673$8.22$112,392.06 12/16/2024Paul B ManningDirectorBuy1,250,000$6.00$7,500,000.00 11/29/2024Seshu TyagarajanCTOSell20,392$4.56$92,987.52 11/29/2024William Garrett NicholsInsiderSell13,935$4.56$63,543.60 10/14/2024Estuardo Aguilar-CordovaMajor ShareholderSell15,000$6.02$90,300.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 10/11/2024Estuardo Aguilar-CordovaMajor ShareholderSell15,000$6.05$90,750.00 10/3/2024Estuardo Aguilar-CordovaMajor ShareholderSell1,800$6.85$12,330.00 (Data available from 1/1/2013 forward) CADL Insider Trading Activity - Frequently Asked Questions Who is on Candel Therapeutics' Insider Roster? The list of insiders at Candel Therapeutics includes Charles Schoch, Estuardo Aguilar-Cordova, Francesca Barone, Jason Amello, Joseph C Papa, Paul B Manning, Paul Peter Tak, Seshu Tyagarajan, and William Garrett Nichols. Learn more on insiders at CADL. What percentage of Candel Therapeutics stock is owned by insiders? 16.60% of Candel Therapeutics stock is owned by insiders. Learn more on CADL's insider holdings. Which Candel Therapeutics insiders have been buying company stock? The following insider purchased CADL shares in the last 24 months: Paul B Manning ($7,500,000.00). How much insider buying is happening at Candel Therapeutics? Insiders have purchased a total of 1,250,000 CADL shares in the last 24 months for a total of $7,500,000.00 bought. Which Candel Therapeutics insiders have been selling company stock? The following insiders have sold CADL shares in the last 24 months: Charles Schoch ($161,214.57), Estuardo Aguilar-Cordova ($193,380.00), Francesca Barone ($210,107.54), Paul Peter Tak ($266,905.37), Seshu Tyagarajan ($647,930.39), and William Garrett Nichols ($67,479.84). How much insider selling is happening at Candel Therapeutics? Insiders have sold a total of 234,498 Candel Therapeutics shares in the last 24 months for a total of $1,547,017.71 sold. Candel Therapeutics Key ExecutivesDr. Paul-Peter Tak FMEDSCI (Age 63)M.D., Ph.D., President, CEO & Director Compensation: $1.12MDr. Estuardo Aguilar-Cordova Inf. (Age 65)M.D., Ph.D., Founder & Director Compensation: $35kDr. Francesca Barone M.D. (Age 46)Ph.D., Chief Scientific Officer Compensation: $506.76kMr. Charles Schoch (Age 39)Interim CFO, VP of Finance & Corporate Controller 1 recent tradesDr. Seshu Tyagarajan Ph.D. (Age 56)Chief Technical & Development Officer Compensation: $335.27kMs. Ileen B. WinickChief People OfficerMs. Susan Stewart J.D. (Age 63)L.L.M., Chief Regulatory Officer Dr. William Garrett Nichols M.D. (Age 55)M.S., Chief Medical Officer 1 recent trades More Insider Trading Tools from MarketBeat Related Companies PAHC Insider Buying ABCL Insider Buying COGT Insider Buying NTLA Insider Buying AUPH Insider Buying WVE Insider Buying ELVN Insider Buying GPCR Insider Buying CDTX Insider Buying ARDX Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional Support This page (NASDAQ:CADL) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Candel Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Candel Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CADL Stock Alerts